Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC — Stella

Home/Endometrial Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Endometrial Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

West China Second University Hospital, Chengdu, Sichuan

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

West China Second University Hospital

Enrollment target

~224 participants

Started

April 2018

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Sex

Female only

Last updated September 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.